A carregar...
PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
The introduction of PD-1/PD-L1 pathway inhibitors has marked a significant milestone in the treatment of various types of solid tumors. The current situation in multiple myeloma (MM) is rather unclear, as distinct research groups have reported discordant results. This discrepancy dominantly concerns...
Na minha lista:
| Publicado no: | Oncoimmunology |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215080/ https://ncbi.nlm.nih.gov/pubmed/28123899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1254856 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|